New CDC Report Shows Syphilis, Gonorrhea, and Chlamydia Rates Increasing Again in 2017

Local Health Departments Work with Healthcare Providers and Other Stakeholders to More Effectively Implement Proven Prevention Strategies Says NACCHO

WASHINGTON, DC, UNITED STATES, September 25, 2018 /EINPresswire.com/ — Today, the Centers for Disease Control and Prevention (CDC) released the Sexually Transmitted Disease (STD) Surveillance Report, 2017. For the fourth year in a row, rates of chlamydia, gonorrhea, and syphilis are increasing, with gonorrhea and syphilis rates being the highest since the early 1990s. Of special concern, there were 918 cases of congenital syphilis (occurs when a mother with untreated syphilis passes the infection to the fetus), which is double the number of cases in 2013, with 64 reported stillbirths.

Reversing these trends will require health departments, healthcare providers, and other stakeholders to work together to more effectively implement proven prevention strategies and develop new tools and approaches to address what isn’t working. For local health departments, this means educating both providers and the public about the increasing risk of syphilis, including congenital syphilis, and the need for early prenatal care, including syphilis testing, to properly treat babies being born with congenital syphilis.

The National Association of County and City Health Officials (NACCHO), representing the nation’s nearly 3,000 local governmental health departments, has worked closely with the CDC to provide its members with the support they need to tackle rising STD rates. Syphilis is a sexually transmitted disease (STD) that can have serious consequences for adults and babies if left untreated, but is simple to cure, including in utero, with the right treatment. This is a widespread problem, as thirty-seven states reported at least one case of congenital syphilis in 2017.

“We simply cannot ignore the barriers to women seeking healthcare, including critical prenatal care, such as poverty, stigma, and lack of health insurance. These barriers also increase the mother’s risk for syphilis,” says NACCHO CEO, Lori Tremmel Freeman. “Prenatal care is crucial for every pregnancy, and getting tested for syphilis just once during pregnancy is unlikely to be sufficient to avoid the consequences of congenital syphilis.”

Syphilis during pregnancy is easily cured with the right antibiotics, but without early and regular prenatal care, cases of syphilis in pregnant women cannot be detected. All pregnant women should be tested for syphilis at their first prenatal visit, but for many, this will be insufficient and a syphilis test at the beginning of the third trimester, approximately 28 weeks’ gestation, and potentially again at delivery, is also needed.

“We must expand our efforts to ensure providers and the public know that syphilis is a real concern during pregnancy and accessing prenatal care including syphilis testing is necessary,” continued Freeman. “Additionally, when any patient receives a syphilis test, we should take advantage of that interaction to discuss the patient and their partner’s pregnancy intentions.”

Local health departments across the country are actively expanding evidence-based strategies to increase identification of STDs; assuring appropriate clinical services for STD clients and their sexual partners; conducting health education and promotion; using surveillance data to inform programmatic efforts and focus on populations disproportionately impacted by STDs; and educating the public, providers, and key stakeholders on effective policy approaches. At this time of increasing STD rates and congenital syphilis cases, it is critical that funding for STD prevention be increased to allow this work to expand.

###

About NACCHO
The National Association of County and City Health Officials (NACCHO) represents the nation's nearly 3,000 local health departments. These city, county, metropolitan, district, and tribal departments work every day to protect and promote health and well-being for all people in their communities. For more information about NACCHO, please visit www.naccho.org.

Theresa Spinner
National Association of County and City Health Officials
202-783-5551
email us here


Source: EIN Presswire

Houston Celebrates Corporate Wellness at 2018 Fall Fit Company Challenge

Teams from companies in Houston show the impact of their wellness programs by training for and conquering a 3-course fitness challenge hosted by Fit Company.

HOUSTON, TEXAS, USA, September 25, 2018 /EINPresswire.com/ — On September 15, 2018 participants from companies located in the Houston area took part in the Fit Company Challenge, a corporate wellness event hosted by the Fit Company Institute. The challenge provided area companies an opportunity to come together as a team and spend a morning exercising, pushing their physical and mental limits and showing the importance of living a healthy lifestyle. Companies split their team into squads of 3 to 4 people who worked together to complete a variety of fitness stations to challenge their fitness level and earn points for their company. Teams chose what level to go through each course which allowed participants of all fitness levels to push their physical fitness without going too far out of their comfort zone.

On event date, volunteers assisted the contenders through the courses from Be Fit Gym (befitgymhouston.com). Participants challenged their strength, conditioning, power, agility, and ended with a test of endurance to show their companies and colleagues that they practice what they preach.

The challenge was held at Houston Sports Park, located a short drive from downtown Houston.

The following is a list of the top finishers in Houston that participated in the 2018 Fall Fit Company Challenge:

Top Companies by Division

Medium Division
1) Valv Technologies
2) Tokio Marine HCC

Small Division
1) The Siegfried Group
2) Gehan Homes

Micro Division
1) Aviva Metals, Inc.
2) HCSS
3) BrightStar Care
4) Premier Pathology Lab

Top Teams Overall (Based on Total Points)

1) Valv Technologies – #2598
2) HCSS – #2601
3) Valv Technologies – #2595
4) Valv Technologies – #2596
5) Tokio Marine HCC – #2591
6) Valv Technologies – #2597
7) The Siegfried Group – #2584
8) Gehan Homes – #2600
9) Tokio Marine HCC – #2590
10) Aviva Metals, Inc. – #2580 (Tie)
10) Tokio Marine HCC – #2592 (Tie)
12) Tokio Marine HCC – #2588
13) Valv Technologies – #2594
14) The Siegfried Group – #2583 (Tie)
14) BrightStar Care – #2587 (Tie)

Top Teams By Course

Course 1 – Level 2

1) #2598 – Valv Technologies (Tie)
1) #2601 – HCSS (Tie)
3) #2591 – Tokio Marine HCC (Tie)
3) #2595 – Valv Technologies (Tie)

Course 1 – Level 1

1) #2594 – Valv Technologies (Tie)
1) #2600 – Gehan Homes (Tie)
3) #2580 – Aviva Metals, Inc.
4) #2592 – Tokio Marine HCC

Course 2 – Level 2

1) #2598 – Valv Technologies (Tie)
1) #2601 – HCSS (Tie)
3) #2595 – Valv Technologies
4) #2596 – Valv Technologies

Course 2 – Level 1

1) #2584 – The Siegfried Group
2) #2580 – Aviva Metals, Inc.
3) #2583 – The Siegfried Group
4) #2591 – Tokio Marine HCC (Tie)
4) #2592 – Tokio Marine HCC (Tie)

Course 3 – Level 2

1) #2598 – Valv Technologies
2) #2596 – Valv Technologies
3) #2601 – HCSS
4) #2595 – Valv Technologies

Course 3 – Level 1

1) #2587 – BrightStar Care
2) #2591 – Tokio Marine HCC
3) #2584 – The Siegfried Group (Tie)
3) #2600 – Gehan Homes (Tie)

Matt Barker
Fit Company Institute
888-994-9964
email us here


Source: EIN Presswire

Dr. Gary Alter Wins Best of Los Angeles Award- “Best Genitourinary Reconstructive Surgeon- 2018”

Dr. Gary Alter

“One of my strengths is my ability to make clinical judgments determined by the specific needs and desires of each patient.” ~Dr. Gary Alter

LOS ANGELES, CA, UNITED STATES, September 25, 2018 /EINPresswire.com/ — Dr. Gary Alter has won the Best of Los Angeles Award for “Best Genitourinary Reconstructive Surgeon- 2018”, according to Aurora DeRose, award coordinator for the Best of Los Angeles Award community.

“No one operation or approach is for everyone,” Dr. Alter contends. “One of my strengths is my ability to make clinical judgments determined by the specific needs and desires of each patient.”

Gary Alter, M.D. is one of the rare doctors (only a handful in the United States), who is certified by both the American Board of Plastic Surgery and the American Board of Urology. He specializes in genital reconstruction and facial and body surgery for transgender patients. He has extensive experience in genital surgery including genital reassignment. His plastic surgical background enables him to assess the ‘whole’ patient and individualize operations.

Services at a Glance:

1. FEMALE GENITAL SURGERY
Physicians have neglected aesthetic surgery of the female external genitalia. However, awareness of female genital aesthetics has increased due to media attention, both from magazines and video.

2. PENIS / SCROTAL SURGERIES
Congenital abnormalities of the penis and scrotum are not uncommon and require reconstructive surgery. Because these deformities can be very challenging, a team approach is often used.

“I frequently operate on these patients with Dr. Richard Ehrlich, a world-renowned pediatric urologist,” Dr. Alter continues. “I believe that the combined input and expertise of a pediatric urologist and a plastic surgeon/urologist (myself) provides the best possible care.”

3. TRANSSEXUAL SURGERY
Dr. Alter and his team, including the office and hospital staff, are committed to serving you during this exciting but anxious stage of your life.

“Our goal is to make your transition as comfortable and easy as possible,” says Dr. Alter.

4. PENIS ENHANCEMENT
“Penile length and girth surgery are other procedures to improve the appearance of the penis and scrotum, such as suprapubic lipectomy and liposuction, and elimination of penoscrotal junction webbing,” Dr. Alter continues.

The “Best of Los Angeles Award” community was formed three years ago and consists of over 4,000 professional members living and working in Southern California. It celebrates the best people, places and things in Los Angeles with a slogan “No Ads. No B.S. Only the Best.”

“The mission of the community is to celebrate the best of Los Angeles, and allow its community members to connect with other members who share the highest standards of quality and integrity,” expresses DeRose. "We're honored to include Dr. Gary Alter into our BoLAA family."

Carl J. of Los Angeles, praises, “Excellent physician and surgeon – one of the top in his field. For privacy reasons, no detailed disclosure of exact procedures necessary, but he surely has earned his board certifications in both plastic surgery and urology – one of only two docs with these double boards in the entire United States. Practice is well run, calls are returned in a timely manner and the operation room in the surgery center on location is bordering on elegant – never seen one with floor to ceiling windows. Highly recommended!”

BEVERLY HILLS
416 N Bedford Dr #400
Beverly Hills, CA 90210
310-275-5566

Aurora DeRose
Aurora DeRose
310-396-6090
email us here


Source: EIN Presswire

Fort Wayne Medical Oncology Convened 2018 Biden Local Cancer Summit

Summit Focused on Ways in Which Cancer Research and Care Saves Lives; Coordinated by Local Community Oncology Alliance Patient Advocacy Network Chapter

Cancer affects us all.”

— Lakshmi Aggarwal, MD, Fort Wayne Medical Oncology and Hematology

FORT WAYNE, INDIANA, UNITED STATES, September 25, 2018 /EINPresswire.com/ — In conjunction with over 450 local summits across the nation and the national Summit in Washington DC, Fort Wayne Medical Oncology and Hematology convened the 2018 Biden Cancer Summit on Friday, September 21, 2018, at the Magee-O’Connor Auditorium on the campus of Indiana Tech. Also participating in the event were Cancer Services of Northeast Indiana and Visiting Nurse.

The Fort Wayne Medical Oncology and Hematology Biden Cancer Summit discussed ways in which cancer research and care saves lives, builds stronger communities and reaches families in moments of critical clinical and emotional need.

Topics at the Summit included:
• Navigating the cancer journey beyond the disease
• Managing difficult conversations
• Preventing cancer through technology, education, and access
• Understanding the oncology research and development pipeline; and survivorship and the path ahead

The Fort Wayne Medical Oncology and Hematology Biden Cancer Community Summit provided the opportunity to learn from the perspectives of patients, caregivers, family members, physicians, nurses, patient navigators, and other care providers. Insights into the realities of living with cancer and the ripple effects a diagnosis can have upon families and communities were featured. Fort Wayne Medical Oncology and Hematology is the longest running oncology practice in Northeast Indiana with more than 40 years of excellence in cancer treatments.

“Cancer affects us all,” noted Lakshmi Aggarwal, M.D., a physician with Fort Wayne Medical Oncology and Hematology. “The impact that a diagnosis can have on an individual, a family, a neighborhood or a community can be devastating. Our goal is to bring new treatments and available community resources into a sharper focus.”

Fort Wayne Medical Oncology and Hematology hosts a local chapter of the Community Oncology Alliance Patient Advocacy Network (CPAN). Its advocacy leader, Lisa J. Poiry RN, OCN, hosts community outreach and educational events like the Summit, which are open to the community. CPAN is a non-cancer-type specific national network representing all members of the cancer community. The organization brings attention to the impact of Medicare legislative policies on cancer patients, specifically the issues affecting access to local and affordable care.

###

About the COA Patient Advocacy Network (CPAN): The Community Oncology Alliance Patient Advocacy Network (CPAN) was created in recognition of the vital role patients should play in advocating for access to local, affordable cancer care for all. CPAN is a non-cancer type-specific, national network representing patients, cancer survivors, caregivers, family members, medical and oncology professionals, and other advocates. To learn more about CPAN visit www.COAadvocacy.org

About Fort Wayne Oncology and Hematology: With recognized specialists in lung and thoracic cancer, leukemia, breast, prostate and colon cancer, Fort Wayne Medical Oncology and Hematology has designed its state-of-the-art facilities as a place of healing, offering an array of comforts and conveniences at its 13 locations while patients receive cutting edge, cancer fighting treatment. Fort Wayne Medical Oncology and Hematology coordinates cancer-fighting treatments close to home. With 13 locations in Northeast Indiana, they streamline cancer care, so patients spend less time on the road and more time at home. Whether that fight involves surgery, radiation, chemotherapy or inpatient care, they work through any hospital network and co-manage care when appropriate. www.fwmoh.com

Nicolas Ferreyros
Community Oncology Alliance
2027298147
email us here


Source: EIN Presswire

Advanced Stem Cell Therapy Treatment Centers Opening in Orlando And Jacksonville Florida

Stem Cell Therapy for Pain Relief

Patients with a variety of medical conditions can benefit from stem cell therapy, especially those with chronic pain and degenerative joint disease of the knee, shoulder and other joints.”

— Fiaz Jaleel MD

ORLANDO, FL, UNITED STATES, September 25, 2018 /EINPresswire.com/ — Personalized Medicine Consultants has announced the launch of two new, treatment centers relieving chronic patient pain through an innovative approach utilizing Stem Cell Therapy.

Fiaz Jaleel MD, specialist physician and owner of Personalized Medicine Consultants, located in Jacksonville and Orlando Florida has started a campaign to educate the public in cutting edge therapies and medical interventions.
Dr. Jaleel stated, “The practice is accepting patients with a variety of medical conditions who would benefit from stem cell therapy, especially those with chronic pain and disability due to rheumatoid arthritis, osteoarthritis and degenerative joint disease of the knee, shoulder and other joints.”

Personalized Medicine Consultants is an anti-aging and regenerative medicine practice that focuses on chronic disease treatment including an integrative pain management approach to patients suffering from painful local or systemic disease.

Dr. Jaleel uses umbilical cord-derived stem cells rather than the patient’s own fat or bone marrow derived stem cells. Umbilical cord stem cells are harvested from healthy, full-term women who willingly donate this valuable tissue. The screening process of each donor is very comprehensive and includes a detailed medical and social history, a physical examination and blood work ensuring that the donor is an excellent candidate.

The use of umbilical cord stem cells is FDA approved only in the treatment of specific disorders. However, there are many research articles on the non-FDA approved uses of cord blood.

This includes:
• Orthopedic conditions such as degenerative joint disease and osteoarthritis
• Neurologic disorders such as Alzheimer’s and Parkinson disease
• Autoimmune disorders such as Crohn’s disease, lupus, multiple sclerosis and rheumatoid arthritis
• Cardiovascular disease including heart attack and heart failure
• Diabetes and diabetic peripheral neuropathy

Click here to go to the original article

If you have an inflammatory disorder or just a nagging painful knee, then you should consider umbilical cord stem cell therapy to help reduce pain and inflammation, and regenerate and repair injured or aging joints or body systems.
You don’t have to depend only upon anti-inflammatory medications, pain pills or cortisone shots. You may be able to avoid surgery, such as a total knee replacement.

You have a choice; you can reach out to Personalized Medicine Consultants. If you are considering the use of umbilical cord stem cells for joint pain, arthritis, diabetes, inflammation or autoimmune disease, consult with a specialist physician at Personalized Medicine Consultants in Jacksonville and Orlando Florida. Dr. Jaleel is an expert on rehabilitation, pain management and anti-aging techniques.

Personalized Medicine Consultants′ mission is to promote longevity and enhance healthier living by providing tools and strategies to prevent age-related disorders that help improve metabolic and psychosocial function. Visit their website at www.personalizedmedmd.com or call 904-744-7474 (Jacksonville) or 407-673-8999 (Orlando) to set up an appointment.

Fiaz Jaleel MD
407-673-8999
email us here
Personalized Medicine Consultants


Source: EIN Presswire

NBT Potential for Ebola Screening Breath Test

Ebola Virus

Healthcare workers in Africa

Ebola Check Point

NBT Potential for Ebola Screening Breath Test – ANCON Medical Seeking Funding for Screening Device to Aid Detection and Treatment Against Ebola Health Crisis

With viruses like Ebola, not only could NBT technology be the difference between life and death, it could make a crucial difference in preventing and controlling an outbreak”

— Wesley Baker – CEO of ANCON Medical

CANTERBURY, KENT, UNITED KINGDOM, September 25, 2018 /EINPresswire.com/ — ANCON Medical Seeking Funding for Advanced Screening Device to Aid Detection and Treatment Against Looming Health Crisis

Democratic Republic of Congo's northeastern region Ministry of Health reported on Monday of a repeat outbreak of the Ebola virus, sickening 150 people and causing the deaths of at least 69 people in the region.

After weeks of control efforts having made impact, doctor’s have expressed concern the outbreak could now worsen due to attacks in the region, movement of people and distrust in the community. "We are now extremely concerned that several factors may be coming together over the next weeks to months to create the potential perfect storm," said Dr Peter Salama, WHO deputy director-general of emergency preparedness and response.

Despite movement restrictions due to political clashes between tribal leaders, teams of healthcare personnel are continuing to conduct fieldwork, including providing vaccinations, according to WHO. But "80% of people that are at risk of Ebola, at direct and immediate risk, were unable to be followed up yesterday in Beni," Salama said Tuesday.

With medical and security professionals in the U.S. and across the world searching for a quick, portable and effective way to screen for the Ebola virus, ANCON Medical is seeking funding for emerging technology that could screen for Ebola and a host of diseases within minutes, simply by testing an individual’s breath.

With appropriate future funding, the company can further develop ANCON’s Nanoparticle Biomarker Tagging (NBT) device, a revolutionary technology that provides one of the most sensitive and non-invasive methods for screening for diseases. Funding will also be used to find the Ebola VOC biomarker, the molecular signature that will alert NBT to the presence of the virus.

“With viruses like Ebola, not only could NBT technology be the difference between life and death, it could make a crucial difference in preventing and controlling an outbreak,” said Wesley Baker, ANCON Medical CEO. “Panic won’t protect vulnerable populations from this terrible virus, but technology like NBT can.”

With sufficient funding, ANCON Medical can complete miniaturization of the technology, allowing it to be used in a variety of settings, such as health clinics in underdeveloped nations, border crossings, airports and other settings where early screenings can provide indications that an individual is infected. Plus, NBT can be programmed to detect a wide variety of diseases and viruses, including cancer and tuberculosis.

Congo is concurrently experiencing a long-term humanitarian crisis that includes intermittent armed conflict, according to WHO. As a result, other health epidemics, including cholera, measles and polio, as well as human trafficking, are flourishing there.

Ebola virus spreads through direct contact with either bodily fluids or objects contaminated by someone ill with the disease, according to the US Centers for Disease Control and Prevention. In some cases, the virus is spread from contact with someone who has died from the disease. The virus enters the body through broken skin or mucous membranes in the eyes, nose or mouth.

On average, Ebola kills about half of those infected, but case fatality rates in individual outbreaks have varied from 25% to 90%. Ebola, which causes fever, severe headache and in some cases haemorrhaging, most commonly affects people and nonhuman primates, such as monkeys, gorillas and chimpanzees. This is a second, separate outbreak that has occurred in Congo so far this year, according to the WHO. A previous outbreak, which began in May and ended in July, affected a western region of the country where 54 cases of Ebola virus were recorded, including 33 deaths.

Since August 8, the Ministry has been inoculating people at high risk of an Ebola infection: primary and secondary contacts of those with confirmed Ebola infections. More than 11,700 people have now been vaccinated, according to Salama, who described this as "the largest scale we have ever seen of the use of Ebola vaccine in the midst of a response."

"Beyond the medical response, the only way to end the Ebola Virus Disease epidemic remains the mobilization and commitment of the community alongside the health authorities," Dr Oly Ilunga Kalenga, Minister of Health, said in a statement.

For more information on ANCON Medical’s NBT, visit http://anconmedical.com/disease-screening/ebola/.
Further information:
https://edition.cnn.com/2018/09/25/health/ebola-update-africa-intl/index.html

Joanna Stephens
Ancon Technologies & Ancon Medical
+44 1227 811705
email us here


Source: EIN Presswire

Braces in Reading, PA Available for Teens and Adults

logo for Reading orthodontist

Berks County orthodontist in Reading, PA is offering the city affordable braces and Invisalign aligners.

The orthodontists in Reading, PA at Exeter Orthodontics offer braces for only $3,995.

READING, PA, UNITED STATES, September 25, 2018 /EINPresswire.com/ — Both teens and adults can find affordable orthodontic care from Exeter Orthodontics in Reading. Both braces and Invisalign aligners are available.

Braces in Reading, PA from Exeter Orthodontics cost only $3,995. This low price, without any hidden fees, takes a burden off parents looking for a way to afford their child’s orthodontic care. X-rays, retainers, and repairs are all included.

“We also cover emergency visits,” says Dr. Soraya Mills, orthodontist in Reading. “This gives our patients peace of mind that we’ll be there for them every step of the way.”

In addition to affordable braces, Invisalign aligners are also available. Invisalign in Reading also costs only $3,995. With transparent aligners, Invisalign is a popular treatment method for adults.

To learn more about Invisalign and braces from the team of Berks County orthodontists in Reading, PA, schedule an appointment with Exeter Orthodontics by visiting http://www.exeterorthodontics.com/request-appointment/.

About Exeter Orthodontics: For several years, Exeter Orthodontics, a Pennsylvania-based orthodontic practice, has offered area patients braces and Invisalign treatments for as low as $3,995. Its team of orthodontists remains dedicated to providing high-quality care at an affordable price. Learn more at http://www.exeterorthodontics.com/.

Meredith Souder-Liss
Exeter Orthodontics
610-401-0559
email us here

Affordable Braces in Reading, PA


Source: EIN Presswire

New England Cancer Specialists to Convene Biden Cancer Community Summit

Advocates in New England Host Local @BidenCancer #BidenCancerSummit Event. Focus on Impact of #Cancer Research & Care

Value-based cancer care is the next step in cancer care. By controlling the rising costs of care and continually improving quality, patients have a better experience and outcomes can be improved”

— Dr. David Benton, New England Cancer Specialists.

SCARBOROUGH, MAINE, UNITED STATES, September 25, 2018 /EINPresswire.com/ — In conjunction with over 450 local Summits across the nation and the national Summit in Washington DC, New England Cancer Specialists hosted a Biden Cancer Community Summit focused on value-based cancer care. This Community Summit was part of the Biden Cancer Initiative’s nationwide effort to double the rate of progress against cancer.

The New England Cancer Specialists Biden Cancer Community Summit was designed to draw in and learn from the perspectives of patients and the cancer patient support network – family members, caregivers, patient navigators, and other care providers for insights on the realities of living with cancer and the ripple effects a diagnosis can have on families and communities. Dr. David Benton, a board-certified oncologist at New England Cancer Specialists, and Janice Martin RN, BSN, OCN, New England Community Oncology Alliance Patient Network (CPAN) Chapter Leader, presented at the Summit.

“Value-based cancer care is the next step in cancer care,” said Dr. David Benton, lead physician at the Topsham office of New England Cancer Specialists. “By controlling the rising costs of cancer care and continually improving quality, patients have a better experience and outcomes can be improved.”

“Cancer affects us all and has an impact on more than just the patient’s health,” noted Benton. “The impact that a diagnosis can have on an individual, the family, and friends can be devastating. Research, targeted treatment options, new drugs, and patient-centric care such as the Oncology Medical Home protocols used at New England Cancer Specialists are all focused on improving both patient care, the patient experience, and ultimately prognosis.”

The New England CPAN chapter and its advocacy leader, Janice Martin RN, BSN, OCN, host community outreach and educational events like the Summit, which are open to the community. CPAN is a noncancer type specific national network representing all members of the cancer community. The organization brings attention to the impact of Medicare legislative policies on cancer patients, specifically the issues affecting access to local and affordable care.

###

About the COA Patient Advocacy Network (CPAN):
The Community Oncology Alliance Patient Advocacy Network (CPAN) was created in recognition of the vital role patients should play in advocating for access to local, affordable cancer care for all. CPAN is a non-cancer type-specific, national network representing patients, cancer survivors, caregivers, family members, medical and oncology professionals, and other advocates. To learn more about CPAN visit www.COAadvocacy.org

About New England Cancer Specialists:
The New England Cancer Specialists’ (NECS) mission is to make life better for people with cancer and blood disorders. To accomplish this, NECS provides patients access to excellence in team-based medical care, and information across the spectrum of cancers and blood disorders. NECS is the region’s largest medical oncology group, with nearly half of Maine’s board-certified medical oncologists on its team. The NECS providers are nationally recognized for their expertise and experience. NECS is one of only twelve practices nationwide—and the only one in Maine—named an Accredited Oncology Medical Home by the Commission on Cancer. www.newenglandcancerspecialists.org/

Nicolas Ferreyros
Community Oncology Alliance
2027298147
email us here


Source: EIN Presswire

Fred Rogers Productions’ Paul Siefken To Discuss Kids & Families At M2Moms® – The Marketing to Moms Conference

marketing to moms

Paul Siefken, President & CEO of Fred Rogers Productions,

marketing to moms

Cooper Munroe, CEO of The Motherhood

50th Anniversary of Mister Rogers Neighborhood

Today’s moms, kids, and families face much different stresses than previous generations of moms. It’s important for marketers to understand and adjust their marketing to the realities of today’s moms.”

— Nan McCann, M2Moms® producer

NEW YORK, NEW YORK, USA, September 25, 2018 /EINPresswire.com/ — Paul Siefken, President & CEO of Fred Rogers Productions, will talk about the company’s work today, its mission, and its commitment to children and families with Cooper Munroe, CEO of The Motherhood, at the 14th Annual M2Moms® – The Marketing to Moms Conference, Oct. 2 & 3, NYC. M2Moms® is designed to help brand marketing executives and their agencies better understand and improve their overall business results with today’s moms.

“During this 50th anniversary of Mister Rogers’ Neighborhood, the life and legacy of Fred Rogers are on many people minds,” according to M2Moms® producer, Nan McCann. “Today’s moms, kids, and families are facing much different challenges and stresses than previous generations of moms. It’s important for marketers to understand and adjust their marketing to the realities of today’s moms. Nobody has been closer to moms and families, for generations, than Fred Rogers Productions through their ongoing production of educational programs for children and their mission of maintaining the legacy of Fred Rogers.”

Siefken said., “We remain committed to inspiring a lifetime of learning in children and to earning the trust of their parents and caregivers every day.” Fred Rogers Productions’ current portfolio includes: Daniel Tiger’s Neighborhood, Peg + Cat, Odd Squad, and Through the Woods, as well as popular apps, games, and the legacy of Mister Rogers’ Neighborhood. Building on its 50-year history of success with exceptional programming for every platform, the company and its programs have earned numerous prestigious awards and honors, including 22 Daytime Emmys, multiple Parents’ Choice Gold Awards, a host of Common- Sense Media Awards, and, most recently, an Institutional Peabody Award, among other accolades.

In addition to Siefken, other M2Moms® speakers include: Enna Allen, Simon Malls; Mandy Arioto, MOPS; Amy Przywara, Sylvan Learning; Patty David, AARP; Elle Walker & Meg Resnikoff, What’s Up Moms; Kurt Workman, Owlet Baby Monitors; Skyler Mattson, WongDoody & June Cleaver is Dead; Michelle Poris, Smarty Pants; Agata Reyes, Destination Maternity; Rachel Curry, Volvo USA. For a full list of speakers go to www.m2moms.com/speakers

“M2Moms® is definitely a ‘don’t miss’ for every exec who markets to moms,” McCann added. “It’s packed with sessions structured to help brands improve and evolve their marketing to moms efforts in a rapidly changing communications environment.”

“That’s why every year M2Moms® is attended by a comprehensive and diverse list of brands including Microsoft, Johnson & Johnson, Evenflo, IKEA, Abbott Nutritionals, GM, Allstate, Heinz, Symantec, Hasbro, Procter & Gamble, Wyeth and Coca-Cola,” according to McCann. “M2Moms® attendance typically sells out.”

The 2018 M2Moms® proudly supports Save the Children. Sponsors include: Presenting Sponsor: Google; Associate Sponsors: AARP, What’s Up Moms, WongDoody; Showcase Sponsors: GfK, Fosina Marketing Group, Sylvan Learning, MOPS International, Famifi, Destination Maternity, BabyPage, Ask Patty, Strottman, Hillside & Knox, Foursquare, PlayWell TEKnologies, Response Media, GreyHealth Group, Raising Dragons, Marketing to Mums, Smarty Pants, Kids II, The Motherhood and Simon Property Group. Media Sponsor: MomTrends Media. Video Content Resource Sponsor: Snippies.

For M2Moms® information: www.m2moms.com or 860.724.2649 x13. M2Moms® is produced by PME® Enterprises LLC, 912 Silas Deane Hwy., Suite 101, Wethersfield, CT 06109.

Nanci McCann
PME Enterprises LLC
8607242649
email us here


Source: EIN Presswire

Dr. Dmitry Samarsky Joins Sirnaomics Senior Management Team as Chief Technology Officer

GAITHERSBURG, MARYLAND, UNITED STATES, September 25, 2018 /EINPresswire.com/ — Sirnaomics, Inc., a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that Dmitry Samarsky, Ph.D., will be joining the company’s senior management team as Chief Technology Officer, taking effect on October 1st, 2018. Dr. Samarsky is one of the pioneers and an internationally recognized expert in the field of RNAi therapeutics. Dr. Samarsky will have two roles: (1) to lead Sirnaomics’ RNAi technology development and secure its leadership position; and (2) to facilitate technology collaborations and therapeutic partnerships.

Dr. Samarsky has been at the inception of RNAi technology and drug development – starting in 2001 as Director of Technology Development at Sequitur (acquired by Invitrogen in 2003) and (in 2005) as Director of Technology Development at Dharmacon (now part of GE). He then served as VP of Technology Development at RXi Pharmaceuticals, USA (2007-2011), SVP of Technology and International Business Development at RiboBio, China (2011-2016) and, most recently, as Chief Scientific Officer at Silence Therapeutics, Germany (2016-2018). Dr. Samarsky has authored more than 40 scientific papers, articles, book chapters, patents and patent applications. He has been an invited speaker at more than 100 international conferences, and currently serves on the Scientific Advisory Boards for the OTS (Oligonucleotide Therapeutics Society), CNAF (China Nucleic Acids Forum), TIDES (Oligonucleotide and Peptide Therapeutics) conference series and OPT (Oligonucleotide and Precision Therapeutics) Congress. Dr. Samarsky received his Ph.D. in biochemistry and molecular biology from University of Massachusetts, Amherst (1998), followed by a postdoctoral position as an H. Arthur Smith Fellow for Cancer Research at University of Massachusetts Medical School (1998-2001).

“We are very happy to have Dr. Dmitry Samarsky join Sirnaomics’ senior management team as the Chief Technology Officer. Dmitry has extensive knowledge in the discovery and development of RNAi therapeutics and is one of the thought leaders for siRNA drug delivery,” Dr. Patrick Lu, President and CEO of the company, commented. “His addition not only strengthens Sirnaomics technology leadership but will also provide an initial presence for the company in the vibrant biotherapeutics arena within the Cambridge/Boston area.”

“I know well and have strong confidence in Sirnaomics’ leadership and outstanding management team,” said Dmitry. “I feel honored and excited to join the company in its quest to discover and develop therapeutics based on cutting edge RNAi technology to treat human diseases.”

About Sirnaomics Clinical Programs

The leading compound of Sirnaomics STP705 is composed of two siRNA oligonucleotides, targeting TGF-β1 and COX-2 mRNA respectively, and formulated in nanoparticles with Histidine-Lysine Co-Polymer (HKP) peptide. Each individual siRNA was demonstrated to inhibit the expression of their target mRNAs and combining the two siRNA’s produces a synergistic effect that diminishes pro-fibrogenic and pro-inflammatory factors. Molecular analyses of the effects of administering the combination demonstrated that the inhibition of these targets had effects on downstream gene products associated with fibrosis including α-SMA, Col1A1, and Col3A1. Additional data suggests that reductions in TGF-β1 and COX-2 led to proapoptotic effects in fibroblasts. These observations suggest that STP705 has the potential for broad application in many inflammatory and fibrotic disease states. STP705 has already entered Phase II clinical study in the USA and received clinical study approval from the Chinese FDA for treatment of hypertrophic Scar. In addition, STP705 has received two orphan drug designations for treatments of Liver Fibrosis: Primary Sclerosing Cholangitis (PSC) and Liver Cancer: Cholangiocarcinoma (CCA) which has received IND green light recently. Other clinical indications for human fibrotic diseases and cancers using different RNAi therapeutic compounds are under development by Sirnaomics.

About Sirnaomics, Inc.

Sirnaomics, Inc., a leading privately held biopharmaceutical company for discovery and development of RNAi therapeutics, is a Delaware corporation headquartered in Gaithersburg, Maryland, USA, with subsidiaries in Suzhou and Guangzhou, China. The company’s mission is to alleviate human suffering and advance patient care in areas of high unmet medical need, with a guiding principle of “Innovation, Global Vision, and Patient-Centered”. Members of the senior management team have extensive experience in the biopharmaceutical, financial, clinical and business management arenas in both the USA and China. The company is supported with funding from Institutional investors, corporate partnerships and government grants. Sirnaomics has developed a strong portfolio of intellectual property with an enriched product pipeline. The therapeutic areas of interest include fibrotic diseases and oncology.

George Ji, Senior VP
Sirnaomics, Inc.
3017401730
email us here


Source: EIN Presswire